Exploring how variations of a protein affect Alzheimer's disease using brain organoids
Understanding the functional impacts of Aβ variants in Alzheimer's disease with human brain organoids
This study is looking at how different types of a protein called amyloid-β might affect the way Alzheimer's disease develops, using tiny lab-grown brain models to help find new ways to understand and treat the condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10523682 on NIH RePORTER |
What this research studies
This research investigates the role of amyloid-β (Aβ) protein variants in the progression of Alzheimer's disease by using human brain organoids, which are lab-grown mini-brains. The team aims to understand how different forms of Aβ can lead to diverse disease patterns and how these patterns might spread throughout the brain. By analyzing the structural and functional characteristics of these protein assemblies, researchers hope to uncover new insights into the mechanisms of Alzheimer's and potential therapeutic approaches. The study combines advanced techniques such as spectroscopic analysis and cryo-electron microscopy to visualize and characterize these proteins.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk due to genetic factors.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for diagnosing and treating Alzheimer's disease by targeting specific protein variants.
How similar studies have performed: Previous research has shown promising results in understanding protein dynamics in neurodegenerative diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Wen, Zhexing — Emory University
- Study coordinator: Wen, Zhexing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.